Skip to main content

Table 2 Somatic morbidity of EOCSs in the "good" and the "poor" SRH groups.

From: Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors

Variables

Good SRH

(N = 89)

Poor SRH

(N = 95)

P

ESa

 

N (%)

N (%)

  

Infarction, angina, stroke

16 (18)

23 (24)

.35

 

Hypertension > 140/90

    

Treated and untreated

31 (44)

31 (42)

.83

 

On antihypertensive medication

13 (15)

19 (20)

.34

 

Diabetes

1 (1)

4 (4)

.20

 

BMI > 28

21 (25)

24 (27)

.74

 

Hyperthyroidism/hypothyroidism

11 (12)

13 (14)

.79

 

Musculo-skeletal diseases

33 (37)

44 (46)

.20

 

Aches and pain > 3 months/last year

44 (49)

64 (67)

.01

.40

EORTC somatic complaints

    

   Nausea

1 (1)

17 (22)

< .001

.77

   Pain

11 (19)

67 (81)

< .001

1.02

   Dyspnoea

21 (23)

49 (52)

< .001

.93

   Insomnia

37 (42)

75 (79)

< .001

.60

   Lack of appetite

5 (6)

33 (35)

< .001

.77

   Constipation

26 (29)

50 (53)

.002

.43

   Diarrhoea

25 (28)

42 (45)

.022

.36

Physical impairment

7 (8)

46 (52)

< .001

1.10

Mental impairment

4 (5)

22 (25)

< .001

.70

Physical activity

  

.55

 

   Minimal exercise

23 (26)

20 (22)

  

   Moderate or more exercises

66 (74)

74 (78)

  

Medication last year

    

   Daily use of medication

57 (64)

84 (91)

< .001

.46

   Use of analgetics

6 (7)

35 (37)

< .001

.77

   Use of psychotropics

13 (15)

47 (50)

< .001

.78

  1. a Effect size.